| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | Nov 9, 2023 | Lexeo Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +227,272 | 14.13% | ✗ | $2.5M |
| Nov 9, 2021 | Nov 12, 2021 | IO Biotech, Inc. | 10% Owner | Buy | 100.0 | +2,142,857 | 54.85% | ✗ | $30M |
| Mar 16, 2020 | Mar 16, 2020 | Enliven Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +187,500 | 15.06% | ✗ | $3M |
| May 9, 2019 | May 13, 2019 | Trevi Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +375,000 | 48.29% | ✗ | $3.8M |
| Nov 21, 2017 | Nov 21, 2017 | scPharmaceuticals Inc. | 10% Owner | Buy | 100.0 | +654,762 | 25.89% | ✗ | $9.2M |